About Josh Boggs
Form D filings for SPR Therapeutics from 2016 to 2024 list Josh Boggs as executive officer.
Josh Boggs first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Josh Boggs in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Josh Boggs works with at each company, as listed on that company's latest Form D.
SPR Therapeutics, Inc. · Form D, Feb 5, 2024
MC
Michael Chuisano
Director
GT
Geoffrey Thrope
Director
BA
Ben Austin
CFO
MB
Maria Bennett
Executive officer and director
NV
Nicholas Valeriani
Director
RB
Robert Blankenship
Director